U.S. Stock News

FTC and 22 states file major lawsuit against Amazon.com (NasdaqGS:AMZN) alleging deceptive ad auction practices that overcharged advertisers by billions of dollars. Regulators claim Amazon secretly altered its advertising auction system over multiple years to increase advertiser costs without clear disclosure. The complaint targets Amazon's high margin advertising operations and seeks financial penalties and potential changes to its ad business. The case adds a new regulatory front for...

Lockheed Martin stock has delivered strong gains over the past five years, yet current checks suggest the market price may still sit below what its cash flows and earnings would justify. Both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and market multiple comparisons point to an undervalued setup rather than a fully priced defense blue chip. Over the past 5 years, Lockheed Martin has returned 80.2%, which shows the stock has already rewarded patient shareholders...

Lennar (LEN) has opened Prentis Branch, a new community of single family homes in Rome, Georgia, just as analyst sentiment has turned cautious ahead of an expected year over year earnings and revenue decline. Lennar's share price has been under pressure, with the stock down 4.6% over the past week and 7.5% over the past three months. The 1-year total shareholder return has declined 35.6%, suggesting recent launches like Prentis Branch have not yet shifted cautious sentiment. Scan a hand...

LivaNova has delivered a solid 46.7% return over the past three years, while a Discounted Cash Flow (DCF) intrinsic value estimate points to the stock trading at a sizable discount to that modelled value. At the same time, standard market multiples look roughly in line with peers, which leaves the stock looking cheaper on cash flow than on earnings benchmarks. A 46.7% return over three years suggests LivaNova shares have already rewarded patient investors, so any valuation edge now matters...

Rising odds of fresh Fed rate hikes, sticky inflation and already painful borrowing costs are reshaping where risk and income can come from in your portfolio. That mix creates both pressure and potential opportunity, especially for stocks tied closely to interest rate trends. This article walks through three U.S. life insurance and annuity providers from our screener that appear especially exposed to today’s policy backdrop, and explains why their stories may be relevant as you consider your...

Delek Logistics Partners has delivered a strong 5 year return, yet the current valuation checks suggest the stock now appears more expensive and may not offer an obvious bargain at recent levels. Over the past 5 years the stock has returned about 100%, which puts recent gains front and center when you assess what is already priced in. The partnership structure and fee based midstream model can support steady cash generation, while exposure to volumes and contract renewals may still create...

On August 21, 2026, Grand Canyon Education, Inc. placed Chief Financial Officer Daniel E. Bachus on paid administrative leave amid a governmental investigation into a non-employee third party’s trades in the company’s stock, while affirming there are no concerns about its financial statements or accounting practices and that the company is not a focus of the probe. The Board’s swift appointment of long-serving Senior Vice President & Controller Chief Accounting Officer Lori Browning as...

In recent comments, J.B. Hunt Transport Services’ intermodal president Darren Field highlighted the company’s emphasis on keeping drayage operations in house amid ongoing industry-wide driver shortages. He argued that tighter control of drayage capacity can help J.B. Hunt maintain service reliability and customer relationships while competitors grapple with constrained driver supply. We’ll now explore how J.B. Hunt’s push to internalize drayage capacity may reinforce its efficiency focus and...

Corning stock has posted very strong share price gains over the past few years, while the valuation checks currently show a split picture, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to undervaluation and the market multiples suggesting the shares are on the expensive side. For investors looking at Corning today, the question is how to weigh that intrinsic value signal against the recent price run and richer market ratios. Over the past 3 years Corning has returned...

Analog Devices, Inc. recently reported third-quarter 2026 results showing sales of US$4,021.9 million and net income of US$1,340.09 million, alongside confirming fourth-quarter guidance calling for about US$4.3 billion in revenue and a mid-point operating margin of 52%. The company also continued returning capital to shareholders through a US$1.10 per-share quarterly dividend set with a September 1, 2026 ex-dividend and record date, and by completing a long-running buyback program that has...

QUALCOMM stock has delivered a strong 56.6% return over the past three years, and the current share price of US$170.48 now appears close to the intrinsic value estimate from a Discounted Cash Flow (DCF) model, while earnings based multiples still point to a cheaper profile. Over three years, QUALCOMM has returned 56.6%, which puts recent strength in focus when judging whether the stock still offers an attractive entry price. The push to grow beyond smartphones into areas like automotive, IoT...

Insiders who purchased Tectonic Therapeutic, Inc. ( NASDAQ:TECX ) shares in the past 12 months are unlikely to be...

IDEAYA Biosciences (NasdaqGS: IDYA) reported a successful FDA Type C meeting for IDE849, aligning on a Phase 3 registrational trial in extensive stage small cell lung cancer. The planned Phase 3 trial will assess IDE849 as a monotherapy and in combination with therapies from AstraZeneca and IDEAYA's own pipeline. The company outlined potential accelerated and full approval endpoints and indicated that the Phase 3 program will include global trial sites. For readers watching how oncology...

Vor Biopharma Stock Performance Snapshot Vor Biopharma (VOR) has drawn investor interest after a month that shows a return of about 6%, along with a past 3 months move of roughly 65%, compared with a 1 year total return decline of about 43%. At a share price of $22.48, Vor Biopharma has seen strong recent momentum, with a 30 day share price return of 6.29% and a 90 day share price return of 64.57%, even though the 1 year total shareholder return is down 42.94%. Scan beyond Vor Biopharma's...

Veracyte (VCYT) has drawn investor attention after recent share price moves, with the stock last closing at US$43.19 and showing mixed performance over the past week, month, and past 3 months. For you as an investor, the key takeaway is that Veracyte’s share price has been relatively steady over the year, with a 1-year total shareholder return of 42.35% and a 3-year total shareholder return of 61.76% signaling earlier strength, while more recent 30 day and 90 day share price returns show...

Viewing insider transactions for Greenwich LifeSciences, Inc.'s ( NASDAQ:GLSI ) over the last year, we see that...

Readers hoping to buy PepsiCo, Inc. ( NASDAQ:PEP ) for its dividend will need to make their move shortly, as the stock...

Insiders who bought US$98.1k worth of iBio, Inc.'s ( NASDAQ:IBIO ) stock at an average buy price of US$1.92 over the...

Last week, you might have seen that Williams-Sonoma, Inc. ( NYSE:WSM ) released its quarterly result to the market. The...

We'd be surprised if Radware Ltd. ( NASDAQ:RDWR ) shareholders haven't noticed that the Chief Operating Officer, Gabi...

Rockwell Automation (ROK) recently rolled out TechConnectIQ Support, a modern remote support service for industrial customers that focuses on reducing downtime and simplifying updates, giving investors fresh information on its service driven model. Alongside the launch of TechConnectIQ and recent moves in AI enabled quality management and OT cybersecurity services, Rockwell Automation’s share price is down 11.6% over the past 30 days but still shows a 6.5% year to date share price gain and a...

Nutanix recently reported its fourth-quarter and full-year 2026 results, with revenue rising to US$757.08 million for the quarter and US$2.85 billion for the year, and issued fiscal 2027 revenue guidance of US$755–765 million for Q1 and US$3.18–3.23 billion for the full year. Alongside these financial results, Nutanix expanded its enterprise AI footprint with new Nutanix Enterprise AI and Kubernetes platform releases and a ChronoScale partnership aimed at production-grade agentic AI...

Coca-Cola FEMSA. de stock has delivered a strong 136.8% return over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to an undervalued profile. With a high overall value score and aligned valuation methods, the current share price leaves investors weighing what is already priced in. A 136.8% gain over five years suggests Coca-Cola FEMSA. de has already rewarded patient holders, so any valuation gap now matters more for...

In the most recent quarter, PTC reported year-on-year revenue declines and fell short of analyst expectations for billings and recurring revenue, while management focused on its Intelligent Product Lifecycle vision and a more durable business model. This contrast between weaker near-term performance and management’s emphasis on building a sturdier long-term operating model raises important questions about how investors weigh current results against future resilience. With PTC underscoring...